Cancer, cardiac among 51 essential drugs under NPPA price cap, check out details
New Delhi: National drug pricing regulator NPPA on Friday said it has capped prices of 51 essential formulations, including those used for the treatment of cancer, pain, heart conditions and skin problems.
The prices have been slashed in the range of 6 to 53 percent.
In separate notifications, the drug price regulator said it has notified ceiling prices of 13 formulations while revising the same for 15 formulations.
Moreover, retail prices of 23 essential formulations have also been notified, National Pharmaceutical Pricing Authority (NPPA) said.
Drugs whose ceiling prices have been capped includes colon or rectal cancer treatment drug oxaliplatin (injection 100mg), Japanese encephalitis vaccine and measles rubbela vaccine.
On the other hand, ceiling prices of drugs including anesthetic sevoflurane, Phytomenadione (Vitamin K1) and tuberculosis prevention medicine BCG vaccine have been revised.
According to highly placed sources in NPPA, the reduction in prices following the latest exercise will range between 6- 53 percent.
NPPA fixes ceiling price of essential medicines of Schedule I under the Drugs (Prices Control) Order (DPCO) 2013.
In respect of medicines that are not under price control, manufacturers are allowed to increase the maximum retail price by 10 percent annually.
The calculation of essential drugs is based on the simple average of all medicines in a particular therapeutic segment with sales of more than 1 percent.
Set up in 1997, NPPA has been entrusted with the task of fixation/revision of prices of pharma products, enforcement of provisions of DPCO and monitoring of prices of controlled and decontrolled drugs.
Following are the details
| Sl. No. | Name of the Scheduled Formulation | Dosage form & Strength | Unit | Ceiling Price (Rs.) |
| (1) | (2) | (3) | (4) | (5) |
| 1. | Oxaliplatin | Injection 100mg (as licensed) | Each Pack | 4055.10 |
| 2. | Acetylsalicylic acid | Effervescent/ Dispersible/ Enteric coated Tablet 100 mg | 1 Tablet | 0.1625 |
| 3. | Japanese Encephalitis Vaccine | 4mcg to 6mcg | Each Pack | 632.95 |
| 4. | Japanese Encephalitis Vaccine | up to 3mcg | Each Pack | 482.22 |
| 5. | Measles Rubbela Vaccine | Each Pack (0.5ml) | 80.22 | |
| 6. | Surfactant | Suspension for intratracheal instillation (As liensed) | Per mg of Phospholipids in the pack | 60.69 |
| 7. | Sevoflurane | Inhalation | 1 ml | 24.12 |
| 8. | Acetylsalicylic acid | Tablet 325mg | 1 Tablet | 0.50 |
| 9. | Desferrioxamine | Powder for Injection 500mg | Each pack | 145.91 |
| 10. | Oxaliplatin | Injection 50mg (as licensed) | Each Pack | 2303.01 |
| 11. | Phytomenadione (Vitamin K1) | Injection 10mg/ml | 1 ML | 43.45 |
| 12. | Glutaraldehyde | Solution 2% | 1 ML | 0.05868 |
| 13. | Anti-D immunoglobulin | Injection 300mcg | Each Pack | 1936.82 |
| 14. | BCG vaccine | Each Dose | 4.32 | |
| 15. | Morphine | SR Tablet 30 mg | 1 Tablet | 4.94 |
| 16 | Alteplase | Powder for Injection 20 mg | Each Pack | 17235.00 |
| 17. | Alteplase | Powder for Injection 50 mg | Each Pack | 35985.00 |
| 18. | Gadobenate | Injection 529 mg/ml | 1 ML | 98.90 |
| 19. | Haemodialysis fluid | As license | 1 ML | 0.03695 |
| 20. | Furosemide | Oral liquid 10 mg/ml | 1 ML | 0.29 |
| 21. | Glucose | Injection 50% | 1 ml | 0.44 |
| 22. | Lignocaine (A) + Adrenaline (B) | Injection 1% (A) + 1:200000 (5 mcg/ml) (B) | 1 ML | 0.41 |
| 23. | Calcium gluconate | Injection 100 mg/ml | 1 ML | 0.50 |
| 24. | Dextran-40 | Injection 10% | 1 ML | 0.38 |
| 25. | Coagulation factor IX | Powder for Injection 600 IU | Each Pack | 11,180.00 |
| 26. | Digoxin | Oral liquid 0.05 mg/ml | 1 ML | 0.29 |
| 27. | Potassium permanganate | Crystals for topical solution | 1 gm | 0.40 |
| 28. | Pilocarpine | Drops 4% | 1 ML | 10.60 |
| Sl. No. | Name of the Scheduled Formulation / Brand Name | Strength | Unit | Manufacturer & Marketing Company | Retail Price (Rs.) |
| (1) | (2) | (3) | (4) | (5) | (6) |
| 1. | Sofosbuvir & Velpatasvir | Each film coated tablet contains: Sofosbuvir 400mg, Velpatasvir 100mg | 28 Tablets | M/s Hetero Labs Ltd. / M/s Abbott India Ltd. | 15625.00 |
| 2. | Sofosbuvir & Velpatasvir | Each film coated tablet contains: Sofosbuvir 400mg, Velpatasvir 100mg | 28 Tablets | M/s Hetero Labs Ltd. / M/s Cadila Healthcare Ltd. | 15625.00 |
| 3. | Sofosbuvir & Velpatasvir | Each film coated tablet contains: Sofosbuvir 400mg, Velpatasvir 100mg | 28 Tablets | M/s Natco Pharma Ltd. /M/s Sun Pharmaceuticals Industries Ltd. | 15625.00 |
| 4. | Sofosbuvir & Velpatasvir | Each film coated tablet contains: Sofosbuvir 400mg, Velpatasvir 100mg | 28 Tablets | M/s Natco Pharma Ltd. / M/s Cipla Ltd. | 15625.00 |
| 5. | Sofosbuvir & Velpatasvir | Each film coated tablet contains: Sofosbuvir 400mg, Velpatasvir 100mg | 28 Tablets | M/s Natco Pharma Ltd. | 15625.00 |
| 6. | Sofosbuvir & Velpatasvir | Each film coated tablet contains: Sofosbuvir 400mg, Velpatasvir 100mg | 28 Tablets | M/s Natco Pharma Ltd. / M/s Mylan Pharmaceuticals Pvt. Ltd | 15625.00 |
| 7. | Sofosbuvir & Velpatasvir | Each tablet contains: Sofosbuvir 400mg, Velpatasvir 100mg | 28 Tablets | M/s Dr. Reddy's Limited | 15,625.00 |
| 8 | Sofosbuvir & Velpatasvir | Each tablet contains: Sofosbuvir 400mg, Velpatasvir 100mg | 28 Tablets | M/s Hetro Labs Ltd. | 15,625.00 |
| 9. | Voglibose + Metformin | Each tablet contains: Voglibose 0.2mg, Metformin 500mg | 1 Tablet | M/s Lupin Ltd. | 4.84 |
| 10. | Voglibose + Metformin | Each tablet contains: Voglibose 0.3mg, Metformin 500mg | 1 Tablet | M/s Lupin Ltd. | 5.76 |
| 11. | Voglibose + Metformin + Glimepirid | Each tablet contains: Voglibose 0.2mg, Metformin 500mg, Glimepirid 1mg | 1 Tablet | M/s Lupin Ltd. | 7.14 |
| 12. | Voglibose + Metformin + Glimepirid | Each tablet contains: Voglibose 0.2mg, Metformin 500mg, Glimepirid 1mg | 1 Tablet | M/s Sanofi India Ltd. | 7.14 |
| 13. | Voglibose + Metformin + Glimepirid | Each tablet contains: Voglibose 0.2mg, Metformin 500mg, Glimepirid 1mg | 1 Tablet | M/s Biocon Ltd. | 7.14 |
| 14. | Voglibose + Metformin + Glimepirid | Each tablet contains: Voglibose 0.2mg, Metformin 500mg, Glimepirid 2mg | 1 Tablet | M/s Lupin Ltd. | 9.05 |
| 15. | Voglibose + Metformin + Glimepirid | Each tablet contains: Voglibose 0.2mg, Metformin 500mg, Glimepirid 2mg | 1 Tablet | M/s Sanofi India Ltd. | 9.05 |
| 16. | Voglibose + Metformin + Glimepirid | Each tablet contains: Voglibose 0.2mg Metformin 500mg Glimepirid 2mg | 1 Tablet | M/s Biocon Ltd. | 9.05 |
| 17. | Voglibose + Metformin + Glimepirid | Each tablet contains: Voglibose 0.3mg, Metformin 500mg, Glimepirid 1mg | 1 Tablet | M/s Lupin Ltd. | 8.52 |
| 18. | Voglibose + Metformin + Glimepirid | Each tablet contains: Voglibose 0.3mg, Metformin 500mg, Glimepirid 1mg | 1 Tablet | M/s Alembic Ltd. | 8.52 |
| 19. | Voglibose + Metformin + Glimepirid | Each tablet contains: Voglibose 0.3mg, Metformin 500mg, Glimepirid 2mg | 1 Tablet | M/s Lupin Ltd. | 10.46 |
| 20. | Diclofenac + Tramadol | Each tablet contains: Diclofenac 75mg, Tramadol 50mg | 1 Tablet | M/s Alembic Ltd. | 9.73 |
| Sl. No . | Name of the Scheduled Formulation | Dosage form & Strength | Unit | Ceili ng Price (Rs.) | Review Order number and date | Existing SO number and date | Manufacturer & Marketing Company respectively |
| (1) | (2) | (3) | (4) | (5) | (6) | (7) | (8) |
| 1. | Trypsin, Bromelain, Rutoside Trihydrate, & Diclofenac Sodium (Volitra Enzo) tablet | Each enteric coated tablet contains: Trypsin 48mg, Bromelain 90mg, Rutoside Trihydrate 100mg, Diclofenac Sodium 50mg | 1 Tablet | 13.91 | 31015/09/2017 -Pricing dated 27.08.2017 | 4131(E) dated 22.12.2016(at Sl. No. 5) | M/s Akums Drugs & Pharmaceuticals Ltd./ M/s Sun Pharmaceuticals Ind. Ltd. |
| Sl. No. | Name of the Scheduled Formulation | Dosage form & Strength | Unit | Ceilin g Price (Rs.) | Review Order number and date | Existing SO number and date |
| (1) | (2) | (3) | (4) | (5) | (6) | (7) |
| 1. | Ceftriaxone | Powder for Injection 1gm | Each Pack | 48.92 | 31015/59/2017-Pricing dated 10.10.2017 | 2058(E) dated 30.6.2017 (at Sl. No. 120) |
| 2. | Chloroquine | Tablet 150mg | 1 Tablet | 0.72 | 31015/32/2017- Pricing dated 24.8.2017 | 2059(E) dated 30.6.2017 (at Sl. No. 23) |
Medical Dialogues had earlier reported that NPPA had fixed the ceiling price for 39 more drug formulations, including those used for the treatment of cancer, tuberculosis, malaria and hepatitis B among others.
Read also: NPPA slashes price of 39 drugs: check out details
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd